Source: Journal of Allergy and Clinical Immunology. Unidade: ICB
Subjects: IMUNOLOGIA, CÉLULAS-TRONCO, IMUNODEFICIÊNCIA DE VARIÁVEL COMUM, HEMATOPOESE, CÉLULAS SANGUÍNEAS, IMUNOLOGIA CELULAR, DOENÇAS AUTOIMUNES, DOENÇAS IMUNOLÓGICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENA, Maria Teresa de la et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, v. 139, n. 4, p. 1282-1292, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2016.07.039. Acesso em: 18 ago. 2024.APA
Morena, M. T. de la, Leonard, D., Torgerson, T. R., Marques, O. C., Slatter, M. A., Aghamohammadi, A., et al. (2017). Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. Journal of Allergy and Clinical Immunology, 139( 4), 1282-1292. doi:10.1016/j.jaci.2016.07.039NLM
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039Vancouver
Morena MT de la, Leonard D, Torgerson TR, Marques OC, Slatter MA, Aghamohammadi A, Chandra S, Favela LM, Bonilla FA, Kanariou M, Damrongwatanasuk R, Kuo CY, Dvorak CC, Meyts I, Chen K, Kobrynski L, Kapoor N, Richter D, DiGiovanni D, Dhalla F, Farmaki E, Speckmann C, Español T, Shcherbina AYU, Hanson ICG, Litzman J, Routes JM, Wong M, Fuleihan R, Seneviratne SL, Small TN, Janda A, Bezrodnik L, Seger R, Raccio AG, Edgar JDM, Chou J, Abbott JK, Montfrans J van, Granado LIG, Bunin N, Kutukculer N, Gray P, Seminario G, Pasic S, Aquino V, Wysocki C, Abolhassani H, Dorsey M, Rundles CC, Knutsen AP, Sleasman JW, Carvalho BTC, Condino-Neto A, Grunebaum E, Chapel H, Ochs HD, Filipovich AH, Cowan M, Gennery A, Cant AJ, Notarangelo LD, Roifman CM. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation [Internet]. Journal of Allergy and Clinical Immunology. 2017 ; 139( 4): 1282-1292.[citado 2024 ago. 18 ] Available from: https://doi.org/10.1016/j.jaci.2016.07.039